Bank of America’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-2,800
Closed -$100K 8072
2014
Q4
$100K Sell
2,800
-7,400
-73% -$221K ﹤0.01% 5888
2014
Q3
$265K Sell
10,200
-112,100
-92% -$3.22M ﹤0.01% 5131
2014
Q2
$4.04M Buy
122,300
+103,600
+554% +$2.99M ﹤0.01% 2748
2014
Q1
$560K Sell
18,700
-167,700
-90% -$5.78M ﹤0.01% 4489
2013
Q4
$5.66M Buy
186,400
+156,100
+515% +$4.3M ﹤0.01% 2365
2013
Q3
$964K Buy
30,300
+22,200
+274% +$509K ﹤0.01% 3984
2013
Q2
$122K Buy
+8,100
New +$112K ﹤0.01% 6041

Other funds holding NPSP

Bank of America's NPSP Position: Q1 2015 in Review

Bank of America sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2015, closing a stake of 396,136 shares — an estimated $14.2M sold.

Bank of America first reported a position in NPSP in Q2 2013 and held it in 7 quarters. The position peaked at $22.5M in Q2 2014. 1 fund tracked by Wall St. Rank holds NPSP as of Q1 2015.

  • Bank of America reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Bank of America sold 396,136 NPS PHARMACEUTICALS INC shares in Q1 2015, an estimated $14.2M.
  • Bank of America first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Bank of America's NPS PHARMACEUTICALS INC position peaked at $22.5M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2015.

Based on Bank of America's 13F filing for Q1 2015, filed 15 May 2015.